Skip to main content
Top
Published in: Critical Care 3/2010

Open Access 01-06-2010 | Research

In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study

Authors: Salvatore Di Somma, Laura Magrini, Valerio Pittoni, Rossella Marino, Antonella Mastrantuono, Enrico Ferri, Paola Ballarino, Andrea Semplicini, Giuliano Bertazzoni, Giuseppe Carpinteri, Paolo Mulè, Maria Pazzaglia, Kevin Shah, Alan Maisel, Paul Clopton

Published in: Critical Care | Issue 3/2010

Login to get access

Abstract

Introduction

Our aim was to evaluate the role of B-type natriuretic peptide (BNP) percentage variations at 24 hours and at discharge compared to its value at admission in order to demonstrate its predictive value for outcomes in patients with acute decompensated heart failure (ADHF).

Methods

This was a multicenter Italian (8 centers) observational study (Italian Research Emergency Department: RED). 287 patients with ADHF were studied through physical exams, lab tests, chest X Ray, electrocardiograms (ECGs) and BNP measurements, performed at admission, at 24 hours, and at discharge. Follow up was performed 180 days after hospital discharge. Logistic regression analysis was used to estimate odds ratios (OR) for the various subgroups created. For all comparisons, a P value < 0.05 was considered statistically significant.

Results

BNP median (interquartile range (IQR)) value at admission was 822 (412 - 1390) pg\mL; at 24 hours was 593 (270 - 1953) and at discharge was 325 (160 - 725). A BNP reduction of >46% at discharge had an area under curve (AUC) of 0.70 (P < 0.001) for predicting future adverse events. There were 78 events through follow up and in 58 of these patients the BNP level at discharge was >300 pg/mL. A BNP reduction of 25.9% after 24 hours had an AUC at ROC curve of 0.64 for predicting adverse events (P < 0.001). The odds ratio of the patients whose BNP level at discharge was <300 pg/mL and whose percentage decrease at discharge was <46% compared to the group whose BNP level at discharge was <300 pg/mL and whose percentage decrease at discharge was >46% was 4.775 (95% confidence interval (CI) 1.76 - 12.83, P < 0.002). The odds ratio of the patients whose BNP level at discharge was >300 pg/mL and whose percentage decrease at discharge was <46% compared to the group whose BNP level at discharge was <300 pg/mL and whose percentage decrease at discharge was >46% was 9.614 (CI 4.51 - 20.47, P < 0.001).

Conclusions

A reduction of BNP >46% at hospital discharge compared to the admission levels coupled with a BNP absolute value < 300 pg/mL seems to be a very powerful negative prognostic value for future cardiovascular outcomes in patients hospitalized with ADHF.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ: Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293: 572-580. 10.1001/jama.293.5.572CrossRefPubMed Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ: Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293: 572-580. 10.1001/jama.293.5.572CrossRefPubMed
3.
go back to reference Krumholtz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI: Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000, 139: 72-77. 10.1016/S0002-8703(00)90311-9CrossRef Krumholtz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI: Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000, 139: 72-77. 10.1016/S0002-8703(00)90311-9CrossRef
4.
go back to reference Cleland JG, Svedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J: The Euro Heart Failure survey program-a survey on the quality of care among patients with heart failure in Europe. Part 1. patient characteristics and diagnosis. Eur Heart J 2003, 24: 442-463. 10.1016/S0195-668X(02)00823-0CrossRefPubMed Cleland JG, Svedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J: The Euro Heart Failure survey program-a survey on the quality of care among patients with heart failure in Europe. Part 1. patient characteristics and diagnosis. Eur Heart J 2003, 24: 442-463. 10.1016/S0195-668X(02)00823-0CrossRefPubMed
5.
go back to reference Fonarow GC: Epidemiology and risk stratification in acute heart failure. Am Heart J 2008, 155: 200-207. 10.1016/j.ahj.2006.10.043CrossRefPubMed Fonarow GC: Epidemiology and risk stratification in acute heart failure. Am Heart J 2008, 155: 200-207. 10.1016/j.ahj.2006.10.043CrossRefPubMed
6.
go back to reference Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis of Acute and Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2008, 29: 2388-2442. 10.1093/eurheartj/ehn309CrossRefPubMed Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis of Acute and Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2008, 29: 2388-2442. 10.1093/eurheartj/ehn309CrossRefPubMed
7.
go back to reference Philbin EF, Di Salvo TG: Prediction of hospital readmission for heart failure development of single risk score based on administrative data. J Am Coll Cardiol 1999, 33: 1560-1566. 10.1016/S0735-1097(99)00059-5CrossRefPubMed Philbin EF, Di Salvo TG: Prediction of hospital readmission for heart failure development of single risk score based on administrative data. J Am Coll Cardiol 1999, 33: 1560-1566. 10.1016/S0735-1097(99)00059-5CrossRefPubMed
8.
go back to reference Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals: Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008, 168: 847-854. 10.1001/archinte.168.8.847CrossRefPubMed Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals: Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008, 168: 847-854. 10.1001/archinte.168.8.847CrossRefPubMed
9.
go back to reference Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E: State of the art: Using natriuretic peptide levels in clinical practice. European Journal of Heart Failure 2008, 10: 824-839. 10.1016/j.ejheart.2008.07.014CrossRefPubMed Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E: State of the art: Using natriuretic peptide levels in clinical practice. European Journal of Heart Failure 2008, 10: 824-839. 10.1016/j.ejheart.2008.07.014CrossRefPubMed
10.
go back to reference Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 2002, 347: 161-167. 10.1056/NEJMoa020233CrossRefPubMed Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 2002, 347: 161-167. 10.1056/NEJMoa020233CrossRefPubMed
11.
go back to reference Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol 2001, 37: 379-385. 10.1016/S0735-1097(00)01156-6CrossRefPubMed Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol 2001, 37: 379-385. 10.1016/S0735-1097(00)01156-6CrossRefPubMed
12.
go back to reference Harrison A, Morrison KL, Krishnaswamy P, Clopton p, Dao Q, Hlavin P, Maisel A: B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002, 39: 131-138. 10.1067/mem.2002.121483CrossRefPubMed Harrison A, Morrison KL, Krishnaswamy P, Clopton p, Dao Q, Hlavin P, Maisel A: B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002, 39: 131-138. 10.1067/mem.2002.121483CrossRefPubMed
13.
go back to reference Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006, 27: 330-337. 10.1093/eurheartj/ehi631CrossRefPubMed Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006, 27: 330-337. 10.1093/eurheartj/ehi631CrossRefPubMed
14.
go back to reference Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB: The N-teminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Card 2005, 95: 948-954. 10.1016/j.amjcard.2004.12.032CrossRefPubMed Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB: The N-teminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Card 2005, 95: 948-954. 10.1016/j.amjcard.2004.12.032CrossRefPubMed
15.
go back to reference Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Maisel A: Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 2008, 51: 1874-1882. 10.1016/j.jacc.2007.12.051CrossRefPubMed Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Maisel A: Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 2008, 51: 1874-1882. 10.1016/j.jacc.2007.12.051CrossRefPubMed
16.
go back to reference Di Somma S, Magrini L, Tabacco F, Marino R, Talucci V, Marrocco F, Cardelli P, Ferri E, Pittoni V: Brain natriuretic peptide (BNP) and n-terminal pro-B-type natriuretic peptide (NT-proBNP) show a different profile in response to acute decompensated heart failure treatment. Congest Heart Fail 2008, 14: 245-250.CrossRefPubMed Di Somma S, Magrini L, Tabacco F, Marino R, Talucci V, Marrocco F, Cardelli P, Ferri E, Pittoni V: Brain natriuretic peptide (BNP) and n-terminal pro-B-type natriuretic peptide (NT-proBNP) show a different profile in response to acute decompensated heart failure treatment. Congest Heart Fail 2008, 14: 245-250.CrossRefPubMed
17.
go back to reference Di Somma S, Magrini L, Mazzone M, De Leva R, Tabacco F, Marino R, Talucci V, Ferri E, Forte P, Cardelli P, Gentiloni N, Pittoni V: Decrease in NT-proBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med 2007, 25: 335-339. 10.1016/j.ajem.2006.08.012CrossRefPubMed Di Somma S, Magrini L, Mazzone M, De Leva R, Tabacco F, Marino R, Talucci V, Ferri E, Forte P, Cardelli P, Gentiloni N, Pittoni V: Decrease in NT-proBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med 2007, 25: 335-339. 10.1016/j.ajem.2006.08.012CrossRefPubMed
18.
go back to reference Di Somma S, Magrini L, Pittoni V, Marino R, Maisel A: Usefulness of serial assessment of Natriuretic Peptdes (NPs) in Emergency Department (ED) for patients with Acute Decompensated Heart Failure (ADHF). Congest Heart Fail 2008, 14: 21-24.CrossRef Di Somma S, Magrini L, Pittoni V, Marino R, Maisel A: Usefulness of serial assessment of Natriuretic Peptdes (NPs) in Emergency Department (ED) for patients with Acute Decompensated Heart Failure (ADHF). Congest Heart Fail 2008, 14: 21-24.CrossRef
19.
go back to reference Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN, Val-HeFT Investigators: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trail (Val-HeFT). Circulation 2003, 107: 1278-1283. 10.1161/01.CIR.0000054164.99881.00CrossRefPubMed Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN, Val-HeFT Investigators: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trail (Val-HeFT). Circulation 2003, 107: 1278-1283. 10.1161/01.CIR.0000054164.99881.00CrossRefPubMed
20.
go back to reference Berger R, Stanek B, Frey B, Sturm B, Huelsmann M, Bergler-Klein J, Pacher R: B-type natriuretic peptides (BNP and PRO-BNP) predict long term survival in patients with advanced heart failure treated with atenolol. J Heart Lung Transplant 2001, 20: 251. 10.1016/S1053-2498(00)00571-4CrossRefPubMed Berger R, Stanek B, Frey B, Sturm B, Huelsmann M, Bergler-Klein J, Pacher R: B-type natriuretic peptides (BNP and PRO-BNP) predict long term survival in patients with advanced heart failure treated with atenolol. J Heart Lung Transplant 2001, 20: 251. 10.1016/S1053-2498(00)00571-4CrossRefPubMed
21.
go back to reference Fisher C, Berry C, Blue L, Morton JJ, McMurray J: N-terminal pro-B type natriuretic peptide, but not the new putative cardiac hormone relaxin predicts prognosis in patients with chronic heart failure. Heart 2003, 89: 879-881. 10.1136/heart.89.8.879PubMedCentralCrossRefPubMed Fisher C, Berry C, Blue L, Morton JJ, McMurray J: N-terminal pro-B type natriuretic peptide, but not the new putative cardiac hormone relaxin predicts prognosis in patients with chronic heart failure. Heart 2003, 89: 879-881. 10.1136/heart.89.8.879PubMedCentralCrossRefPubMed
22.
go back to reference Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA: NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP study. Eur J Heart Fail 2004, 6: 343-350. 10.1016/j.ejheart.2004.01.009CrossRefPubMed Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA: NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP study. Eur J Heart Fail 2004, 6: 343-350. 10.1016/j.ejheart.2004.01.009CrossRefPubMed
23.
go back to reference Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS: B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg med 2002, 39: 131-138. 10.1067/mem.2002.121483CrossRefPubMed Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS: B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg med 2002, 39: 131-138. 10.1067/mem.2002.121483CrossRefPubMed
24.
go back to reference Cheng V, Kazanegra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001, 37: 386-391. 10.1016/S0735-1097(00)01157-8CrossRefPubMed Cheng V, Kazanegra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001, 37: 386-391. 10.1016/S0735-1097(00)01157-8CrossRefPubMed
25.
go back to reference Bettencourt P, Ferreira S, Azevedo A, Ferreira A: Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med 2002, 113: 215-219. 10.1016/S0002-9343(02)01184-1CrossRefPubMed Bettencourt P, Ferreira S, Azevedo A, Ferreira A: Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med 2002, 113: 215-219. 10.1016/S0002-9343(02)01184-1CrossRefPubMed
26.
go back to reference O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham , McDonald K: The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail 2007, 13: 50-55. 10.1016/j.cardfail.2006.09.003CrossRefPubMed O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham , McDonald K: The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail 2007, 13: 50-55. 10.1016/j.cardfail.2006.09.003CrossRefPubMed
27.
go back to reference Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G: Biological variations for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003, 92: 628-631. 10.1016/S0002-9149(03)00741-0CrossRefPubMed Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G: Biological variations for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003, 92: 628-631. 10.1016/S0002-9149(03)00741-0CrossRefPubMed
28.
go back to reference Cohen-Solal , Logeart D, Bidan Huang, Danlin Cai, Nieminen MS, Mebazaa A: Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severely acutely decompensated heart failure. J Am Coll Cardiol 2009, 53: 2343-2348. 10.1016/j.jacc.2009.02.058CrossRefPubMed Cohen-Solal , Logeart D, Bidan Huang, Danlin Cai, Nieminen MS, Mebazaa A: Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severely acutely decompensated heart failure. J Am Coll Cardiol 2009, 53: 2343-2348. 10.1016/j.jacc.2009.02.058CrossRefPubMed
29.
go back to reference Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, Hulot JS, Thomas D, Piwowarska W, Komajda M: Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 2004, 25: 1763-1764. 10.1016/j.ehj.2004.07.038CrossRef Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, Hulot JS, Thomas D, Piwowarska W, Komajda M: Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 2004, 25: 1763-1764. 10.1016/j.ehj.2004.07.038CrossRef
30.
go back to reference Ababsa R, Jourdain P, Sadeg N, Deschamps P, Jacoly C, Funck F: Proposition d'un seuil de BNP discriminant dans la population très âgée présentant une insuffisance cardiaque. Annales de biologie clinique 2004, 64: 437-440. Ababsa R, Jourdain P, Sadeg N, Deschamps P, Jacoly C, Funck F: Proposition d'un seuil de BNP discriminant dans la population très âgée présentant une insuffisance cardiaque. Annales de biologie clinique 2004, 64: 437-440.
31.
go back to reference Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC: Predischarge B-type natriuretic peptide assay for dentifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004, 43: 635-641. 10.1016/j.jacc.2003.09.044CrossRefPubMed Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC: Predischarge B-type natriuretic peptide assay for dentifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004, 43: 635-641. 10.1016/j.jacc.2003.09.044CrossRefPubMed
32.
go back to reference Maisel AS: Use of BNP levels in monitoring hospitalized heart failure patients with Heart Failure. 2003, 8: 339-344. Maisel AS: Use of BNP levels in monitoring hospitalized heart failure patients with Heart Failure. 2003, 8: 339-344.
33.
go back to reference Gheorghiade M: Treatment of congestion in acute heart failure syndromes: importance, strategies, and challenges. Am J Med 2006, 119: S1-S2. 10.1016/j.amjmed.2006.09.010CrossRefPubMed Gheorghiade M: Treatment of congestion in acute heart failure syndromes: importance, strategies, and challenges. Am J Med 2006, 119: S1-S2. 10.1016/j.amjmed.2006.09.010CrossRefPubMed
34.
go back to reference Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, McCord J, Nowak RM, Aumont MC, Duc P, Hollander JE, Wu AH, McCullough PA, Maisel AS: Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 2004, 116: 363-368. 10.1016/j.amjmed.2003.10.028CrossRefPubMed Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, McCord J, Nowak RM, Aumont MC, Duc P, Hollander JE, Wu AH, McCullough PA, Maisel AS: Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 2004, 116: 363-368. 10.1016/j.amjmed.2003.10.028CrossRefPubMed
35.
go back to reference Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP: Relationship between B-type natriuretic peptide and pulmonary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005, 45: 1667-1671. 10.1016/j.jacc.2005.01.046CrossRefPubMed Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP: Relationship between B-type natriuretic peptide and pulmonary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005, 45: 1667-1671. 10.1016/j.jacc.2005.01.046CrossRefPubMed
36.
go back to reference Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L: How often do we need to measure BNP blood test levels in patients admitted to hospital for acute decompensated heart failure? Role of serial measurements to improve short term prognostic stratification. Int J Cardiol 2010, 140: 88-94. 10.1016/j.ijcard.2008.11.020CrossRefPubMed Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L: How often do we need to measure BNP blood test levels in patients admitted to hospital for acute decompensated heart failure? Role of serial measurements to improve short term prognostic stratification. Int J Cardiol 2010, 140: 88-94. 10.1016/j.ijcard.2008.11.020CrossRefPubMed
Metadata
Title
In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study
Authors
Salvatore Di Somma
Laura Magrini
Valerio Pittoni
Rossella Marino
Antonella Mastrantuono
Enrico Ferri
Paola Ballarino
Andrea Semplicini
Giuliano Bertazzoni
Giuseppe Carpinteri
Paolo Mulè
Maria Pazzaglia
Kevin Shah
Alan Maisel
Paul Clopton
Publication date
01-06-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9067

Other articles of this Issue 3/2010

Critical Care 3/2010 Go to the issue